8
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Literature Alerts

Pages 685-692 | Published online: 29 Sep 2008

References

  • A novel and simple type of liposome carrier for recombinant interleukin-2. KANAOKA, E., TAKAHASHI, K., YOSHIKAWA, T., JizomoTo, H., NISHIHARA, Y., and HIRANO, K. Journal of Pharmacy and Pharmacology, 2001, 53, 295–302.
  • A rapid and easy procedure of biosensor fabrication by microencapsulation of enzyme in hydrophilic synthetic latex films. Application to the amperometric determination of glucose. COSNIER, S., SZUNERITS, S., MARKS, R. S., NOVOA, A., PUECH, L., PEREZ, E., and RICO-LATTES, I. Electrochemistry Communications, 2000, 2, 851–855.
  • Accelerated stability studies of microencapsulated anhydrous milk fat. HARDAS, N., DANVIRIYAKUL S., FOLEY, J. L., NAWAR, W. W., and CHINACHOTI, P. Lebensmittel Wissenschaft und Technologie: Food Science and Technology, 2000, 7, 506–513.
  • Activity of mammalian secreted phospholipase A(2) from inflammatory peritoneal fluid towards PEG-liposomes. Early indications. VERMEHREN, C., JORGENSEN, K., SCHIFFELERS, R., and FROKJAER, S. International Journal of Pharmaceutics, 2001, 214, 93–98.
  • Agarose enhances the viability of intraperitoneally implanted microencapsulated L929 fibroblasts. LAHOOTI, S., and SEFTON, M. V. Cell Transplantation, 2000, 9, 785–796.
  • Aggregation behavior of poly(N-isopropylacrylamide) microspheres. MAKIN°, K., KADO, H., and OnsmmA, H. Colloids and Surfaces B—Biointerfaces, 2001, 20, 347–353.
  • Air-filled polymeric microcapsules from emulsions containing different organic phases. BJERKNES, K., BRAENDEN, J. U., BRAENDEN, J. E., SKURTVEIT, R., SMISTAD, G., and AGERKVIST, I. Journal of Microencapsulation, 2001, 18, 159–171.
  • An analytic dosimetry study for the use of radionuclide-liposome conjugates in internal radiotherapy. EmFIETzomou, D., KOSTARELOS, K., and SGOUROS, G. Journal of Nuclear Medicine, 2001, 42, 499–504.
  • Antibody targeting of doxorubicin-loaded liposomes suppresses the growth and metastatic spread of established human lung tumor xenografts in severe combined immunodefi-cient mice. SUGANO, M., EGILMEZ, N. K., YOKOTA, S. J., CHEN, F. A., HARDING, J., HUANG, S. K., and BANKERT, R. B. Cancer Research, 2000, 60, 6942–6949.
  • Antioxidative effect of fluvastatin, an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A reductase, on peroxidation of phospholipid liposomes. YAMAMOTO, A., IcnnuatA, K., and Hosm, K. Journal of Pharmacy and Pharmacology, 2001, 53, 227–232.
  • Architecture of polymeric superstructures: locking of cubic lattices by graft polymerization from photofunctional core-shell polymer microspheres. Ismzu, K., and Simtvrom, S. Journal of Materials Science Letters, 2000, 19, 2105–2107.
  • Assessment of regional myocardial blood flow and coronary flow reserve using myocardial contrast echocardiography with power pulse imaging: comparison with neutron activated microsphere. KHANKIRAWATANA, B., KHANKIRAWATANA, S., LOF, J., HALLGREN-GoLKA, J., PORTER, T. R., and JIANG, L. Journal of the American College of Cardiology, 2001, 37, 423A.
  • Biological activity of rhBMP-2 released from PLGA microspheres. OLDHAM, J. B., Lu, L., Znu, X., PORTER, B. D., HEFFERAN, T. E., LARSON, D. R., CURRIER, B. L., MIKOS, A. G., and YASZEMSKI, M. J. Journal of Biomechanical Engineering—Transactions of the ASME, 2000, 122, 289–292.
  • Bulk-quantity Si nanosphere chains prepared from semi-infinite length Si nanowires. PENG, H. Y., WANG, N., SHI, W. S., ZHANG, Y. F., LEE, C. S., and LEE, S. T. Yourna/ of Applied Physics, 2001, 89, 727–731.
  • Caelyx (stealth liposomal doxorubicin) in the treatment of advanced breast cancer. RANSON, M. R., CHEESEMAN, S., WHITE, S., and MARGISON, J. Critical Reviews in Oncology Hematology, 2001, 37, 115–120.
  • Capabilities of liposomes for topological transformation. NOMURA, F., NAGATA, M., INABA, T., HIRAMATSU, H., HOTAN i, H., and TAKIGUCHI, K. Proceedings of the National Academy of Sciences (USA), 2001, 98, 2340–2345.
  • Catheter-delivered in vivo gene transfer into rat myocardium using the fusigenic liposomal mediated method. SHINMURA, K., MORISHITA, R., AOKI, M., HIGAKI, J., OGIHARA, T., KANEDA, Y., and Ti, M. Japanese Heart Journal, 2000, 41, 633–647.
  • Cationic liposome-mediated gene transfer to rat salivary epithelial cells in vitro and in vivo. BACCAGLINI, L., HOQUE, A. T. M. S., WELLNER, R. B., GOLDSMITH, C. M., REDMAN, R. S.,BANKAR, V., KINGMAN, A., BARNHART, K. M., WHEELER, C. J. and BAUM, B. J. Journal of Gene Medicine, 2001, 3, 82–90.
  • Cell culture and animal studies for intracerebral delivery of borocaptate in liposomal formulation. Ji, B. Q., CHEN, W., Lu, D. R., and HALPERN, D. S. Drug Delivery, 2001, 8, 13–17.
  • Characterization of calcitonin-containing liposome formulations for intranasal delivery. LAW, S. L., and Smn, C. L. Journal of Microencapsulation, 2001, 18, 211–221.
  • Characterization of microsphere embolism-induced impairment of learning and memory function and the cholinergic system. TAKAGI, K., MIYAKE, K., TAKAGI, N., TADOKORO, M., NAKAYAMA, E., NAGAKURA, A., and TAKEO, S. Biological El Pharmaceutical Bulletin, 2001, 24, 43–49.
  • Characterization of sterically stabilized cisplatin liposomes by nuclear magnetic resonance. PELEG-SHULMAN, T., GIBSON, D., COHEN, R., ARRA, R., and BARENHOLZ, Y. Biochimica et Biophyska Actct—Biomembranes, 2001, 1510, 278–291.
  • Chitosan based pentazocine microspheres for intranasal systemic delivery: development and biopharmaceutical evaluation. SANKAR, C., RANI, M., SRIVASTAVA, A. K., and MISHRA, B. Pharmazie, 2001, 56, 223–226.
  • Chitosan/gelatin microspheres prepared by modified emulsification and ionotropic gelation. Snu, X. Z., and Znu, K. J. Journal of Mkroencapsulation, 2001, 18, 237–245.
  • Clinical and preclinical pharmacology of liposomal vincristine. WEBB, M. S., SARRIS, A. H., CABANILLAS, F., MAYER, L. D., BALLY, M. B., BURGE, C., and CULL'S, P. R. journal of Liposome Research, 2000, 4, 501–512.
  • Colloidal stability of IgG- and IgY-coated latex microspheres. DAVALOS -PANTOJA, L., ORTEGA-VINUESA, J. L., BASTOS-GONZALEZ, D., and HIDALGO-ALVAREZ R. Colloids and Surfaces B—Biointerfaces, 2001, 20, 165–175.
  • Continuous release of endostatin from microencapsulated engineered cells for tumor therapy. JoKi, T., MACHLUF, M., ATALA, A., ZHU, J. H., SEYFRIED, N. T., DUNN, I. F., ABE, T., CARROLL, R. S., and BLACK, P. M. Nature Biotechnology, 2001, 19, 35–39.
  • Controlled delivery of taxol from poly(ethylene glycol)-coated poly(lactic acid) micro-spheres. DAs, G. S., Rao, G. H. R., WILSON, R. F., and CHANDY, T. Journal of Biomedical Materials Research, 2001, 55, 96–103.
  • Controlled detachment of immobilized liposomes on polymer gel support. KHALEQUE, M. A., Ono, T., OKUMURA, Y., and MITANI, M. Chemistry Letters, 2000, 12, 1402–1403.
  • Cross-linked beta-cyclodextrin microcapsules: preparation and properties. PARIOT, N., EDWARDS-LEVY, F., ANDRY, M. C., and LEVY, M. C. International Journal of Pharmaceutics, 2000, 211, 19–27.
  • Degradable dextran microspheres for the controlled release of liposomes. STENEKES, R. J. H., LOEBIS, A. E., FERNANDES, C. M., CROMMELIN, D. J. A., and HENNINK, W. E. International Journal of Pharmaceutics, 2001, 214, 17–20.
  • Depletion of systemic macrophages by liposome-encapsulated clodronate attenuates striatal macrophage invasion and neurodegeneration following local endotoxin infusion in gerbils. ZITO, M. A., KOENNECKE, L. A., MCAULIFFE, M. J., MCNALLY, B., VAN ROOIJEN, N., and HEYES, M. P. Brain Research, 2001, 892, 13–26.
  • Design of triptorelin loaded nanospheres for transdermal iontophoretic administration. NICOLI, S., SANTI, P., COUVREUR, P., COUARRAZE, G., COLOMBO, P., and FATTAL, E. International Journal of Pharmaceutics, 2001, 214, 31–35.
  • Dielectric behavior and magnetic properties of poly(styrene-co-acrylic acid) metal microspheres. WANG, Y. M., and PAN, C. Y. European Polymer Journal, 2001, 37, 699-704. DOTAP cationic liposomes prefer relaxed over supercoiled plasmids. EVEN-CHEN, S., and BARENHOLZ, Y. Biochimica et Biophysica Actct—Biomembranes, 2000, 1509, 176–188.
  • Drug delivery by phospholipase A(2) degradable liposomes. DAVIDSEN, J., VERMEHREN, C., FROKJAER, S., MOURITSEN, O. G., and JORGENSEN, K. International Journal of Pharmaceutics, 2001, 214, 67–69.
  • Durability of sodium sulfate-treated polylysine-alginate microcapsules. DARRABIE, M., FREEMAN, B. K., KENDALL, W. F., HOBBS, H. A., and OPARA, E. C. Journal of Biomedical Materials Research, 2001, 54, 396–399.
  • Effect of adsorption of bovine serum albumin on liposomal membrane characteristics. YOKOUCHI, Y., TSUNODA, T., Imuuw, T., YAMAUCHI, H., YOKOYAMA, S., SAKAI, H., and ABE, M. Colloids and Surfaces B—Biointerfaces, 2001, 20, 95–103.
  • Effect of liposome composition and cholesterol on the cellular uptake of stavudine by human monocyte/macrophages. KATRAGADDA, A., BRIDGMAN, R., and BETAGERI, G. Cellular Molecular Biology Letters, 2000, 4, 483–493.
  • Effect of surfactants in soybean lecithin liposomes studied by energy transfer between NBD-PE and N-Rh-PE. BAPTISTA, A. L. F., COUTINHO, P. J. G., OLIVEIRA, M. E. C. D. R., and GOMES, J. I. N. R. Journal of Liposome Research, 2000, 4, 419–429.
  • Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. YAROSH, D., KLI IN, J., O'CONNOR, A., HAWK, J., RAFAL, E., and WOLF, P. Lancet, 2001, 357, 926–929.
  • Effective prodrug liposome and conversion to active metabolite. SADzuNA, Y. Current Drug Metabolism, 2000, 1, 31–48.
  • Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes. HARRINGTON, K. J., MOHAMMADTAGHI, S., USTER, P. S., GLASS, D., PETERS, A. M., VILE, R. G., and STEWART, J. S. W. Clinical Cancer Research, 2001, 7, 243–254.
  • Effects of lysozyme and bovine serum albumin on membrane characteristics of dipalmi-toylphosphatidylglycerol liposomes. TSUNODA, T., ImuEA, T., KADOTA, M., YAMAZAKI, T., YAMAUCHI, H., KWON, K. O., YOROYAMA, S., SAKAI, H., and ABE, M. Colloids and Surfaces B—Biointerfaces, 2001, 20, 155–163.
  • Effects of the antibiotic peptide microcin J25 on liposomes: role of acyl chain length and negatively charged phospholipid. RINTOUL, M. R., DE ARCURI, B. F., and MORERO, R. D. Biochimka et Biophysica Actct—Biomembranes, 2000, 1509, 65–72.
  • Efficacy of liposomes and hyperthermia in a human tumor xenograft model: importance of triggered drug release. KONG, G., ANYARAMBHATLA, G., PETROS, W. P., BRAUN, R. D., COLVIN, O. M., NEEDHAM, D., and DEWHIRST, M. W. Cancer Research, 2000, 60, 6950–6957.
  • Efficient gene delivery using anionic liposome-complexed polyplexes (LPDH). Guo, W. J., and LEE, R. J. Bioscience Reports, 2000, 20, 419–432.
  • Electromagnetic eigenoscillations and fields in a dielectric microsphere with multilayer spherical stack. BURLAK, G., KOSHEVAYA, S., SANCHEZ-MONDRAGON, J., and GRIMALSKY, V. Optics Communications, 2001, 187, 91–105.
  • Encapsulating aspirin into a surfactant-free ethyl cellulose microsphere using non-toxic solvents by emulsion solvent-evaporation technique. YANG, C. Y., TSAY, S. Y., and TSIANG, R. C. C. Journal of Microencapsulation, 2001, 18, 223–236.
  • Encapsulation of bovine serum albumin in poly(lactide-co-glycolide) microspheres by the solid-in-oil-in-water technique. CAsTELLANos, I. J., CARRASQUILLO, K. G., LOPEZ, J. D., ALVAREZ, M., and GRIEBENOW, K. Journal of Pharmacy and Pharmacology, 2001, 53, 167–178.
  • Enhancement of anti-metastatic activity of pentoxifylline by encapsulation in conventional liposomes and sterically stabilized liposomes in murine experimental B16F10 mela-noma model. SANT, V. P., NAGARSENKER, M. S., RAO, S. G. A., and GUDE, R. P. Journal of Pharmacy and Pharmacology, 2000, 52, 1461–1466.
  • Experimental examination of a targeted hyperthermia system using inductively heated ferromagnetic microspheres in rabbit kidney. JoNEs, S. K., and WINTER, J. G. Physics in Medicine and Biology, 2001, 46, 385–398.
  • Fluorescent liposome flow markers for microscale particle image velocimetry. SINGH, A. K., CUMMINGS, E. B., and THROCKMORTON, D. J. Analytical Chemistry, 2001, 73, 1057–1061.
  • Formulation and release characteristics of poly(lactic-co-glycolic acid) microspheres con-taining chemically modified protein. Km, T. K., and BURGESS, D. J. Journal of Pharmacy and Pharmacology, 2001, 53, 23–31.
  • Fourth International Conference on Liposome Advances Progress in Drug and Vaccine Delivery—December 13–17. 1999. GREGORIADIS, G. Journal of Liposome Research, 2000, 4, IX.
  • Frequency tuning of the whispering-gallery modes of silica microspheres for cavity quantum electrodynamics and spectroscopy. VON KLITZING, W., LONG, R., ILCHENKO, V. S., HARE, J., and LEFEVRE-SEGUIN, V. Optics Letters, 2001, 26, 166–168.
  • Glycolipid and monoclonal immunoglobulin-glycolipidic liposomes spread onto high ionic strength buffers: evidence for a true monolayer formation. GIRARD-EGROT, A. P., CHAUVET, J. P., BOULLANGER, P., and COULET, P. R. Langmuir, 2001, 17, 1200–1208.
  • High-entrapment liposomes for 6-Mercaptopurine—a prodrug approach. TANEJA, D., NAMDEO, A., MISHRA, P. R., KHOPADE, A. J., and JAIN, N. K. Drug Development and Industrial Pharmacy, 2000, 12, 1315–1319.
  • Hydrocarbon dispersion of nanospherical silica by a sol-gel process. 1. Tetraethoxysilane homopolymerization. PEDROSO, M. A. S., Dias, M. L., AZUMA, C., and MomE, C. G. Colloid and Polymer Science, 2000, 278, 1180–1186.
  • Improving the thermal properties of textiles using PCM microcapsules. PAUSE, B. Teksti/, 2000, 49, 718–720.
  • In vitro sustained release of human immunoglobulin G from biodegradable microspheres. WONG, H. M., WANG, J. J., and WANG, C. H. Industrial CI Engineering Chemistry Research, 2001, 40, 933–948.
  • Induction of aerobic peroxidation of liposomal membranes by bis(cyclopentadieny1)-vanadium(IV) (acetylacetonate) complexes. KOTCHEVAR, A. T., Gnosn, P., DuMEz, D. D., and UCKUN, F. M. journal of Inorganic Chemistry, 2001, 83, 151–160.
  • Interaction of cationic partial dendrimers with charged and neutral liposomes. PUROHIT, G., SAKTHIVEL, T., and FLORENCE, A. T. International Journal of Pharmaceutics, 2001, 214, 71–76.
  • Interactions of PC/Chol and PS/Chol liposomes with human cells in vitro. PAPADIMITRIOU, E., and ANTIMISIARIS, S. G. Journal of Drug Targeting, 2000, 5, 335.
  • Intra-tumoural injection of Y-90 microspheres into an animal model of hepatoma. CHEN, S. D., HSIEH, J. F., Tsm, S. C., LIN, W. Y., CHENG, K. Y., and WANG, S. J. Nuclear Medicine Communications, 2001, 22, 121–125.
  • Investigation of thin films formed from liposome suspensions on quartz substrate. KAISHEVA, M., ALEXANDROVA, L., SPASSOV, I., and DIAKOVA, B. Colloids and Surfaces B—Biointerfaces, 2001, 20, 137–143.
  • Involvement of TGF-beta in inhibitory effects of negatively charged liposomes on nitric oxide production by macrophages stimulated with LPS. MATSUNO, R., ARAMAKI, Y., and
  • TSUCHIYA, S. Biochemical and Biophysical Research Communications, 2001, 281, 614–620.
  • Leishmanicidal activity of stearylamine-bearing liposomes in vitro. AFRIN, F., DEY, T., ANAM, K., and ALI, N. Journal of Parisitology, 2001, 87, 188–193.
  • Liposomal amphotericin B. SUNDAR, S. Lancet, 2001, 357, 801–802.
  • Liposomal amphotericin B vs fluconazole for prophylax of Candid spp infections in children given hematopoietic stem cell transplantation: A phase III randomized, multicenter study. PESSION, A., CASTELLINI, C., GIORGIANI, G., CESAR°, S., PRETE, A., FAGIOLI, F., FAVRE, C., GIRALDI, E., RONDELLI, R., PICCOLROVAZZ I, S., and LOCATELLI, F. Blood, 2000, 96, 3401.
  • Liposomal bleomycin: increased therapeutic activity and decreased pulmonary toxicity in mice. ARNDT, D., ZEISIG, R., BECHTEL, D., and FICHTNER, I. Drug Delivery, 2001, 8, 1–7.
  • Liposomal delivery systems for local anesthetics. GRANT, G. J., and BANSINATH, M. Regional Anesthesia and Pain Medicine, 2001, 26, 61–63.
  • Liposome-based formulations for the delivery of oligonucleotides. FATTAL, E., DUBERNET, C., and COUVREUR, P. STP Pharma Sciences, 2001, 11, 31–44.
  • Liposome disruption detected by surface plasma resonance at lower concentrations of a peptide antibiotic. CHEN, H. M., WANG, W., and SMITH, D. K. Langmuir, 2000,16, 9959-9962. Liposome elimination by non-phagocytic cells of the liver. SCHERPHOF, G. L., DAEMEN, T., ROMERO, E. D., and Kips, J. A. A. M. Journal of Liposome Research, 2000, 4, 431-442. Liposome-mediated DNA uptake and transient expression in Thermotoga. Yu, J. S., VARGAS, M., MITYAS, C., and NoLL, K. M. Extremophi/es, 2001,5, 53–60.
  • Liposomes and micelles to target the blood pool for imaging purposes. TORCHILIN, V., BABICH, J., and WEISSIG, V. Journal of Liposome Research, 2000, 4, 483–499.
  • Liposomes as sustained release system for human interferon-gamma: biopharmaceutical aspects. VAN SLOOTEN, M. L., BOERMAN, O., ROMOREN, K., KEDAR, E., CROMMELIN, D. J. A., and STORM, G. Biochimica et Biophysica Acta—Molecular and Cell Biology of Lipids, 2001, 1530, 134–145.
  • Liposomes labeled with biotin and horseradish peroxidase: a probe for the enhanced amplification of antigen-antibody or oligonucleotide-DNA sensing processes by the precipitation of an insoluble product on electrodes. ALFONTA, L., SINGH, A. K., and WILLNER, I. Analytical Chemistry, 2001, 73, 91–102.
  • Local endostatin treatment of gliomas administered by microencapsulated producer cells. READ, T. A., SORENSEN, D. R., MAHESPARAN, R., ENGER, P. O., TIMPL, R., OLSEN, B. R., HJELSTLIEN, M. H. B., HARALDSET H, O., and BJERKVIG, R. Nature Biotechnology, 2001, 19, 29–34.
  • Manipulation of macrophage activities using liposomes. HONING, H., VAN ROOIJEN, N., and VAN DEN BERG, T. K. Journal of Liposome Research, 2000, 4, 359–389.
  • Measurement of tumor blood flow using colored dye extraction microspheres in two rat tumor models. IWAMARU, A., WATANABE, M., Yu, S., OHTSUKA, T., HORINOUCHI, H., and KOBAYASHI, K. International Journal of Oncology, 2001, 18, 227–232.
  • Microencapsulated bovine chromaffin cell xenografts into hemiparkinsonian rats: a drug-induced rotational behavior and histological changes analysis. XUE, Y. L., GAO, J. M., XI, Z. F., WANG, Z. F., Li, X. J., Cul, X., Luo, Y., Li, C. H., WANG, L. N., ZHOU, D., SUN, R., and SUN, A. M. Artificial Organs, 2001, 25, 131–135.
  • Microencapsulation of acid dyes in mixed lecithin/surfactant liposomic structures. GOMES, J. I. N. R., and BAPTISTA, A. L. F. Textile Research Journal, 2001, 71, 153–156.
  • Microencapsulation of ascorbic acid: effect of process variables on product characteristics. UDDIN, M. S., HAWLADER, M. N. A., and ZHU, H. J. Journal of Microencapsulation, 2001, 18, 199–209.
  • Microencapsulation of human parathyroid cells: an 'in vitro' study. PICARIELLO, L., BENVENUTI, S., RECENTI, R., FORMIGLI, L., FALCHETTI, A., MORELLI, A., MASI, L., TONELLI, F., CICCHI, P., and BRANDI, M. L. Journal of Surgical Research, 2001, 96, 81–89.
  • Microencapsulation of pesticides and their improved handling safety. Tsuji, K. Journal of Microencapsulation, 2001, 18, 137–147.
  • Microfluidic device for combinatorial fusion of liposomes and cells. STROMBERG, A., KARLSSON, A., RYTTSEN, F., DAVIDSON, M., CHIU, D. T., and ORWAR, O. Analytical Chemistry, 2001, 73, 126–130.
  • Microsphere add/drop performs well at 5 Gbit/s. [ANON]. Laser Focus World, 2001, 10.
  • Modulation of estrogen receptor gene transcription in breast cancer cells by liposome delivered decoy molecules. PIVA, R., DEL SENNO, L., LAMBERTINI, E., PENOLAZZI, L., and NASTRUZZI, C. Journal of Steroid Biochemistry and Molecular Biology, 2000, 75, 121–128.
  • Morphology, drug distribution, and in vitro release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion solvent extraction/ evaporation method. YANG, Y. V., CHUNG, T. S., and NG, N. P. Biomaterials, 2001, 22, 231–
  • Myocardial microcirculation dysfunction in pacing-induced heart failure dogs: evaluation with neutron activated microspheres and power pulse inversion imaging. JIANG, L., SHEN, X. D., ZHU, G. Q., KHANKIRAWATANA, B., and WANG, W. journal of the American College of Cardiology, 2001, 37, 416A.
  • Nanoconstruction of microspheres and microcapsules using proton-induced phase transi-tions: molecular self-recognition by diamide diacids in water. PHANSTIEL, O., LACHICOTTE, R. J., TORRES, D., RICHARDSON, M., MATSUI, H., SCHAFFER, H., ADAR, F., Liu, J., and SECONI, D. Chemistry of Materials, 2001, 13, 264–272.
  • Nanoengineered structures for holding and manipulating liposomes and cells. WILSON, C. F., SIMPSON, G. J., CHIU, D. T., STROMBERG, A., ORWAR, O., RODRIGUEZ, N., and ZARE, R. N. Analytical Chemistry, 2001, 73, 787–791.
  • New cationic liposomes for gene transfer into mammalian cells with high efficiency and low toxicity. CHoi, J. S., LEE, E. J., JANG, H. S., and PARK, J. S. Bioconjugate Chemistry, 2001, 12, 108–113.
  • Novel acoustic drug-encapsulated liposomes for site-specific delivery. TIUKINHOY, S. D., HUANG, S. L., KHAN, A. A., MACDONALD, R. C., and MCPHERSON, D. D. Journal of the American College of Cardiology, 2001, 37, 256A.
  • Ocular tolerability and in vivo bioavai lability of poly(ethylene glycol) (PEG)-coated polyethy1-2-cyanoacrylate nanosphere-encapsulated acyclovir. FRESTA, M., FONTANA, G., Buc,ow, C., CAVALLARO, G., GIAMMONA, G., and PuGosi, G. Journal of Pharmaceutical Sciences, 2001, 90, 288–297.
  • Optical bistability of stimulated-emission lines in Sm3+ -doped glass microspheres. HAYAKAWA, T., Ooism, H., and NoGAmi, M. Optics Letters, 2001, 26, 84–86.
  • Parameters influencing the determination of liposome lamellarity by P-31-NMR. FROHLICH, M., BRECHT, V., and PESCHKA-SUSS, R. Chemistry and Physics of Lipids, 2001, 109, 103–112.
  • Pegylated liposomal doxorubicin in the treatment of cutaneous T-cell lymphoma. PRINCE, H. M., SEYMOUR, J. F., RYAN, G., and MCCORMACK, C. Journal of the American Academy of Dermatology, 2001, 44, 149.
  • Pegylated liposomal doxorubicin in the treatment of cutaneous T-cell lymphoma—Reply. WOLLINA, U., and GRAEFE, T. journal of the American Academy of Dermatology, 2001, 44, 150.
  • Peroxidation of proteins, and lipids in suspensions of liposomes, in blood serum,, and in mouse myeloma cells. GEBICKI, J. M., Du, J., COLLINS, J., and TWEEDDALE, H. Acta Biochimka Polonka, 2000,4, 901–911.
  • pH-sensitive liposomes as a carrier for oligonucleotides (ODN): development of a new methodology to follow physicochemical changes along with pH of native and ODN loaded liposomes. DE OLIVEIRA, M. C., DUBERNET, C., PATERNOSTRE, M., FATTAL, E., COUVREUR, P., and OLLIVON, M. STP Pharma Sciences, 2001, 11, 103–107.
  • Phase II study of liposomal doxorubicin in patients with advanced colorectal cancer. SHIELDS, A. F., LANGE, M., and ZALUPSKI, M. M. American Journal of Clinical Oncology—Cancer Clinical Trials, 2001, 24, 96–98.
  • Photons confined in hollow microspheres. ARTEMYEV, M. V., WOGGON, U., and WANNEMACHER, R. Applied Physics Letters, 2001, 78, 1032–1034.
  • Plasmid DNA encapsulation and release from solvent diffusion nanospheres. HIROSUE, S., MULLER, B. G., MULLIGAN, R. C., and LANGER, R. Journal of Controlled Release, 2001, 70, 231–
  • Polyinosinic acid and polycationic liposomes attenuate the hepatic clearance of circulating plasmid DNA. MINCHIN, R. F., CARPENTER, D., and ORR, R. J. Journal of Pharmacology and Experimental Therapeutics, 2001, 296, 1006–1012.
  • Polymeric nanosphere formed from temperature-responsive polymer composed of (N,N-dimethylamino)ethyl methacrylate and ethyl acrylamide. LEE, T. B., No, K. T., Clio, S. H., Kim, S. S., SEO, J. K., LEE, J. H., and Yux, S. H. Journal of Polymer Sciences Part B—Polymer Physics, 2001, 39, 594–600.
  • Polyphosphazene microspheres for insulin delivery. CALICETI, P., VERONESE, F. M., and LORA, S. International Journal of Pharmaceutics, 2000, 211, 57–65.
  • Positively charged gelatin microspheres as gastric mucoadhesive drug delivery system for eradication of H-pylori. WANG, J., TAUCHI, Y., DEGUCHI, Y., MORIMOTO, K., TABATA, Y., and IKADA, Y. Drug Delivery, 2000, 7, 237–243.
  • Potential of Gd-DTPA-mannan liposome particles as a pulmonary perfusion MRI contrast agent—an initial animal study. SUGA, K., MIKAWA, M., OGASAWARA, N., OKAZAKI, H., and MATSUNAGA, N. Investigative Radiology, 2001, 36, 136–145.
  • Preclinical and clinical evidence for efficient opsonization of poly(ethyleneglycol)-liposomes. STORM, G., LAVERMAN, P., DAMS, E. T. M., OUSSOREN, C., CORSTENS, F. H. M., OYEN, W. J. G., and BOERMAN, O. C. Journal of Liposome Research, 2000, 4, 461–466.
  • Preparation and characterization of biodegradable or enteric-coated microspheres contain-ing the protease inhibitor camostat. UCHIDA, T., YASUDA, N., and MATSUYAMA, K. Journal of Pharmacy and Pharmacology, 2001, 53, 255–261.
  • Preparation and characterization of hCG-loaded polylactide or poly(lactide-co-glycolide) microspheres using a modified water-in-oil-in-water (w/o/w) emulsion solvent eva-poration technique. Znu, K. J., JIANG, H. L., Du, X. Y., WANG, J., Xu, W. X., and Liu, S. F. Journal of Mkroencapsulatiort, 2001, 18, 247–260.
  • Preparation and characterization of magnetic amphiphilic polymer microspheres. DING, X. B., Li, W., ZHENG, Z. H., ZHANG, W. C., DENG, J. G., PENG, Y. X., CHAN, A. S. C., and Li, P. Journal of Applied Polymer Science, 2001,79, 1847–1851.
  • Preparation and evaluation of a hepatocyte targeting pH-sensitive liposome. WEN, S. Y., WANG, X. H., LIN, L., GUAN, W., and WANG, S. Q. Progress in Biochemistry and Biophysics, 2001, 28, 113–117.
  • Preparation and evaluation of insulin-loaded polylactide microspheres using factorial design. Hu, Y. Q., Guo, J. X., WANG, L. J., TAN, R. X., and ZHEN, L. Y. Drug Development and Industrial Pharmacy, 2000, 12, 1309–1313.
  • Preparation and properties of arsonolipid containing liposomes. FATOUROS, D., GORTZI, O., KLEPETSANIS, P., ANTIMISIARIS, S. G., STUART, M. C. A., BRISSON, A., and IOANNOU, P. V. Chemistry and Physics of Lipids, 2001, 109, 75–89.
  • Preparation of desmopressin-containing liposomes for intranasal delivery. LAW, S. L., HUANG, K. J., and Cnou, H. Y. Journal of Controlled Release, 2001, 70, 375–382.
  • Production of protein-loaded polymeric microcapsules by compressed CO2 in a mixed solvent. ELVASSORE, N., BERTUCCO, A., and CALICETI, P. Industrial CI Engineering Chemistry Research, 2001, 40, 795–800.
  • Quantum mechanical model of localized electrons on the surface of polymer nanospheres. GRAY, S. K., SUMPTER, B. G., NOID, D. W., and BARNES, M. D. Chemical Physics Letters, 2001, 333, 308–313.
  • Re: Concentration of ofloxacin in canine prostate tissue and prostate fluid after intraprostatic injection of biodegradable sustained-releasing microspheres containing ofloxacin—Reply by authors. BARK, J. Y., HYUN, J. S., LEE, J. Y., Kim, J., CHO, Y. H., LEE, J. H., PARK, J. S., and Kim, M. O. journal of Urology, 2001, 165, 544–545.
  • Receptor-mediated gene delivery to HepG2 cells by ternary assemblies containing cationic liposomes and cationized asialoorosomucoid. SINGH, M., KISOON, N., and ARIATTI, M. Drug Delivery, 2001, 8, 29–34.
  • Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer. BATIST, G., RAMAKRISHNAN, G., RAO, C. S., CHANDRASEKHARAN, A., GUTHEIL, J., GUTHRIE, T., SHAH, P., KHOJASTEH, A., NAIR, M. K., HOELZER, K., TKACZUK, K., PARK, Y. C., and LEE, L. W. Journal of Clinical Oncology, 2001, 19, 1444–1454.
  • Reduction of structural perturbations in bovine serum albumin by non-aqueous microen-capsulation. CARRASQUILLO, K. G., CARRO, J. C. A., ALEJANDRO, A., TORO, D. D., and GRIEBENOW, K. Journal of Pharmacy and Pharmacology, 2001, 53, 115–120.
  • Safety, toxicokinetics and tissue distribution of long-term intravenous liposomal amphoter-icin B (AmBisome (R)): a 91-day study in rats. BEKERSKY, I., BOSWELL, G. W., HILES, R., FIELDING, R. M., BUELL, D., and WALsn, T. J. Pharmaceutical Research, 2000, 17, 1494–1502.
  • Salt and cosolvent effects on ionic drug loading into microspheres using an O/W method. AL-MAAJEn, A., and FLANAGAN, D. R. Journal of Controlled Release, 2001, 70, 169–181.
  • Screening effect of PEG on avidin binding to liposome surface receptors. KAASGAARD, MOURITSEN, O. G., and JORGENSEN, K. International Journal of Pharmaceutics, 2001, 214, 63–65.
  • Selective protein interactions with phosphatidylserine containing liposomes alter the steric stabilization properties of poly(ethylene glycol). CHiu, G. N. C., BALLY, M. B., and MAYER, L. D. Biochimica et Biophysica Actct—Biomembranes, 2001, 1510, 56–69.
  • Separation of americium from europium by biopolymer microcapsules enclosing Cyanex 301 extractant. MIMURA, H., Hosm, H., AKIBA, K., and ONODERA, Y. Journal of Radioanalytkal and Nuclear Chemistry, 2001, 247, 375–379.
  • Sialyl Lewis(x)-liposomes as vehicles for site-directed, E-selectin-mediated drug transfer into activated endothelial cells. STAHN, R., GRITTNER, C., ZEISIG, R., KARSTEN, U., FELIX, S. B., and WENZEL, K. Cellular and Molecular Life Sciences, 2001, 58, 141–147.
  • Single-fraction irradiation has no effect on uptake of radiolabeled pegylated liposomes in a tumor xenograft model. HARRINGTON, K. J., ROWLINSON-BUSZA, G., USTER, P. S., VILE, R. G., PETERS, A. M., and STEWART, J. S. W. International Journal of Radiation Oncology, Biology and Physics, 2001, 49, 1141–1148.
  • Site-specific administration of antisense oligonucleotides using biodegradable polymer microspheres provides sustained delivery and improved subcellular biodistribution in the neostriatum of the rat brain. KHAN, A., SOMMER, W., FUXE, K., and AKHTAR, S. Journal of Drug Targeting, 2000, 5, 319–334.
  • Spatial distribution of nutritive and nonnutritive vascular routes in perfused rat hindlimb muscle using microspheres. VINCENT, M. A., RATTIGAN, S., CLARK, M. G., BERNARD, S. L., and GLENNY, R. W. Microvascular Research, 2001, 61, 111–121.
  • Spectrophotometric determination of drug partition coefficients in dim yristoyl-L-alpha-phosphatidylcholine/water: a comparative study using phase separation and liposome suspensions. RODRIGUES, C., GAMEIRO, P., REIS, S., LIMA, J. L. F. C., and DE CASTRO, B. Analytica Chimica Acta, 2001, 428, 103–109.
  • Stabilizing insulin-like growth factor-I in poly(D,L-lactide-co-glycolide) microspheres. MEINEL, L., ILIA, O. E., ZAPF, J., MALFANTI, M., MERKLE, H. P., and GANDER, B. Journal of Controlled Release, 2001, 70, 193–202.
  • Structural behaviours of DPPC/water liposomes. BOTA, A., CSISZAR, A., DRUCKER, T., HORVATH, B., BORBELY, S., KRIECHBAUM, M., REZ, G., HAUBOLD, H. G., and VAD, T. Magyar Kemiai Folyoirat, 2000, 106, 488–502.
  • Structural resonances in Raman spectrum of TiBa glass microsphere. WANG, J. Y., Xu, X. X., ZHANG, C. P., ZHANG, C. Z., WANG, W. M., and Lu, Y. journal of Infrared and Millimeter Waves, 2001, 20, 30–32.
  • Study of biodistribution of methotrexate-loaded bovine serum albumin nanospheres in mice. SANTHI, K., DHANARAJ, S. A., KOSHY, M., PONNUSANKAR, S., and SURESH, B. Drug Development and Industrial Pharmacy, 2000, 12, 1293–1296.
  • Study of F-actin interaction with planar and liposomal bilayer phospholipid membranes. GRIGORIEV, P. A., TARAHOVSKY, Y. S., PAVLIK, L. L., UDALTSOV, S. N., and MOSHKOV, D. A. Iubmb Life, 2000, 50, 227–233.
  • Synergistic effect of gelatin microspheres incorporating TGF-beta 1 and a physical barrier for fibrous tissue infiltration on skull bone formation. HONG, L., MIYAMOTO, S., HASHIMOTO, N., and TABATA, Y. Journal of Biomaterials Science—Polymer Edition, 2000, 12, 1357–1369.
  • Tamoxifen encapsulation within polyethylene glycol-coated nanospheres. A new antiestro-gen formulation. BRIGGER, I., CHAMINADE, P., MARSAUD, V., APPEL, M., BESNARD, M., GURNY, R., RENOIR, M., and COUVREUR, P. International Journal of Pharmaceutics, 2001, 214, 37–42.
  • Targeting of antibiotics in bacterial infections using pegylated long-circulating liposomes. BAKKER-WOUDENBERG, I. A. J. M., SCHIFFELERS, R. M., TEN KATE, M. T., STORM, G., Guo, L., and WORKING, P. Journal of Liposome Research, 2000, 4, 513–521.
  • Targeting of liposomal andrographolide to L-donovani-infected macrophages in vivo. SINHA, J., MUKHOPADHYAY, S., DAs, N., and BAsu, M. K. Drug Delivery, 2000, 7, 209–213.
  • The effect of lipid composition on receptor-mediated in vivo gene transfection using mannosylated cationic liposomes in mice. KAWAKAMI, S., SATO, A., YAMADA, M., YAMASHITA, F., and HASHIDA, M. STP Pharma Sciences, 2001, 11, 117–120.
  • The effects of freeze-drying on the stability of liposomes to jet nebulization. BRIDGES, P. A., and TAYLOR, K. M. G. journal of Pharmacy and Pharmacology, 2001, 53, 393–398.
  • The measurement of beclomethasone dipropionate entrapment in liposomes: a comparison of a microscope and an HPLC method. BATAVIA, R., TAYLOR, K. M. G., CRAIG, D. Q. M., and THOMAS, M. International Journal of Pharmaceutics, 2001, 212, 109–119.
  • The role of complement activation in hypersensitivity to pegylated liposomal doxorubicin (DOXIL (R)). SZEBENI, J., BARANYI, L., SAVAY, S., LUTZ, H. U., JELEZAROVA, E., BUNGER, R., and ALVING, C. R. Journal of Liposome Research, 2000, 4, 467–481.
  • The use of scintigraphic imaging as a tool in the development of liposome formulations. GOINS, B. A., and PHILLIPS, W. T. Progress in Lipid Research, 2001, 40, 95–123.
  • Therapeutic efficacy of liposomal gentamicin in clinically relevant rat models. SCHIFFELERS, R. M., STORM, G., and BAKKER-WOUDENBERG, I. A. J. M. International Journal of Pharmaceutics, 2001, 214, 103–105.
  • Therapeutic efficacy of liposome-encapsulated gentamicin in rat Klebsiella pneumoniae pneumonia in relation to impaired host defense and low bacterial susceptibility to gentamicin. SCHIFFELERS, R. M., STORM, G., TEN KATE, M. T., and BAKKER-WOUDENBERG, I. A. J. M. Antimicrobial Agents and Chemotherapy, 2001, 45, 464–470.
  • Tissue distribution of pulmonary liposomal tetrahydrocannabinol (THC). LEACH, J. D., HUNG, O. R., SHEK, P., TIKUISIS, P., and ZAMECNIK, J. Clinical Pharmacology CI Therapeutics, 2001, 69, P50.
  • Tumour dosimetry in human liver following hepatic yttrium-90 microsphere therapy. CAMPBELL, A. M., BAILEY, I. H., and BURTON, M. A. Physics in Medicine and Biology, 2001, 46, 487–498.
  • Ultrafine palladium particles immobilized on polymer microspheres. WANG, P. H., and PAN, C. Y. Colloid and Polymer Science, 2001, 279, 171–177.
  • Uptake by vascular smooth muscle cells plays an important role in targeting of lipid microspheres incorporating prostaglandin E-1 into a thickened intima. CHINO, Y., MINAGAWA, T., KOHNO, Y., TODA, Y., MURAKAMI, S., and HIGUCHI, S. Life Sciences, 2001, 68, 933–942.
  • Use of Tc-99m-labeled liposomes encapsulating blue dye for identification of the sentinel lymph node. PHILLIPS, W. T., KLIPPER, R., and GOINS, B. Journal of Nuclear Medicine, 2001, 42, 446–451.
  • Usefulness of repeated direct intratumoral gene transfer using hemagglutinating virus of Japan-liposome method for cytosine deaminase suicide gene therapy. KANYAMA, H., TOMITA, N., YAMANO, T., AIHARA, T., MIYOSHI, Y., OHUE, M., SEKIMOTO, M., SAKITA, I., TAMAKI, Y., KANEDA, Y., SENTER, P. D., and MONDEN, M. Cancer Research, 2001, 61, 14–18.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.